Subash Chandra Sonkar

Dr. Subash Chandra Sonkar

Maulana Azad Medical College, New Delhi, Delhi, International
+7
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in European Journal of Pharmacology
Verified
Journal Article
Closed access
VSVivek Kumar Soni
Vivek Kumar Soni
AMArundhati Mehta
Arundhati Mehta
YRYashwant Kumar Ratre
Yashwant Kumar Ratre
ATAtul Kumar Tiwari
Atul Kumar Tiwari
AAAjay Amit
Ajay Amit
NVNaveen Kumar Vishvakarma
Naveen Kumar Vishvakarma

8 September 2010 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
APAchchhe L Patel
Achchhe L Patel
DSDivya Sachdev
Divya Sachdev
PNPoonam Nagpal
Poonam Nagpal
UCUma Chaudhry
Uma Chaudhry
Subash Chandra SonkarSubash Chandra Sonkar
Subash Chandra Sonkar
DSDaman Saluja
Daman Saluja
Background: Screening women for Chlamydia trachomatis infection in developing countries is highly desirable because of asymptomatic infection. The existing diagnostic methods in developing countries are not effective and their sensitivity fall below 45.0% which leads to further spread of infection. There is an urgent need for improved and cost effective diagnostic tests that will reduce the burden of sexually transmitted infections in the developing world. Methods: Prevalence of C. trachomatis infection among women visiting gynaecology department of Hindu Rao hospital in Delhi, India was determined using Roche Amplicor Multi Well Plate kit (MWP) as well as using in-house PCR assay. We used 593 endocervical swabs for clinical evaluation of the in-house developed assay against Direct Fluorescence Assay (DFA; Group I n = 274) and Roche Amplicor MWP kit (Group II, n = 319 samples) and determined the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) of the in-house developed assay. Results: We detected 23.0% positive cases and there was a higher representation of women aged 18-33 in this group. An in-house PCR assay was developed and evaluated by targeting unique sequence within the gyrA gene of C. trachomatis. Specificity of the reaction was confirmed by using genomic DNA of human and other STI related microorganisms as template. Assay is highly sensitive and can detect as low as 10 fg of C. trachomatis DNA. The resolved sensitivity of in-house PCR was 94.5% compared with 88.0% of DFA assay. The high specificity (98.4%) and sensitivity (97.1%) of the in-house assay against Roche kit and availability of test results within 3 hours allowed for immediate treatment and reduced the risk of potential onward transmission. Conclusions: The in-house PCR method is cost effective (~ 20.0% of Roche assay) and hence could be a better alternative for routine diagnosis of genital infection by C. trachomatis to facilitate improved screening and treatment management.

3 April 2024 in Infectious Medicine
Verified
Journal Article
Open access
SKSmriti Krishna
Smriti Krishna
CKChhaya Kurrey
Chhaya Kurrey
MYManisha Yadav
Manisha Yadav
SMShakuntala Mahilkar
Shakuntala Mahilkar
Subash Chandra SonkarSubash Chandra Sonkar
Subash Chandra Sonkar
BKBidhan Chandra Koner
Bidhan Chandra Koner
In 2022, just before the COVID-19 pandemic ended, many countries noticed a viral monkeypox outbreak. Monkeypox virus, a zoonotic pathogen, causes a febrile illness in humans and resembles smallpox. Prevention strategies encompass vaccination, strict infection control measures, and avoiding contact with infected persons. As monkeypox and related poxviruses continue to pose challenges, ongoing surveillance, early diagnosis, prompt isolation, and effective control measures are crucial for limiting transmission and mitigating the impact of outbreaks on public health. This review provides valuable insights into the evolution of the monkeypox virus and its various modes of transmission, including postmortem transmission, and offers an overall perspective on the guidelines issued by the Government of India to prevent and effectively control the spread of this disease.

3 May 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Subash Chandra SonkarSubash Chandra Sonkar
Subash Chandra Sonkar
KWKirti Wasnik
Kirti Wasnik
AKAnita Kumar
Anita Kumar
VSVineeta Sharma
Vineeta Sharma
PMPratima Mittal
Pratima Mittal
DSDaman Saluja
Daman Saluja
Utility of syndromic case management (SCM) in women visiting obstetrics & gynecology department needs to be evaluated as it is subjective and imperfect. Consequently, antibiotic resistance has accelerated along with increased risk of infection to the partners. To understand the effectiveness and/or inadequacies of SCM, 11000 women were recruited and examined by clinicians for infection by Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV), Bacterial vaginosis (BV) and others. Amongst these patients, 1797 (16.3%) reported vaginal discharge (VD). Other symptoms included: vaginitis (97%), cervicitis (75%), genital ulcers (60%), abnormal vaginal discharge (55%) and lower abdominal pain (48%). The patients were treated for single or co-infections using pre-packed National Aids Control Program III STI/RTI Kits. However, based on PCR diagnostics, 1453/1797 (81%) subjects were uninfected for NG/TV/CT. Amongst 344 (19%) infected patients, 257 (75%) carried infection with single pathogen (TV/NG/CT) while 87/344 (25%) were co-infected with multiple pathogens. Prevalence of TV, NG & CT was 4%, 7% and 8% respectively. Co-infection with CT + NG was highest, 51% (44/87), whereas, co-infection with CT + TV was 21% and NG + TV was 18% while co-infection with all three pathogens was 1.3%. We conclude that SCM is imprecise and successful intervention requires accurate and confirmatory diagnostic approach.

29 April 2021 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
ADAbhishek Dubey
Abhishek Dubey
GKGarima Kotnala
Garima Kotnala
TMTUHIN KUMAR MANDAL
TUHIN KUMAR MANDAL
Subash Chandra SonkarSubash Chandra Sonkar
Subash Chandra Sonkar
VSVijay K. Singh
Vijay K. Singh
BKBidhan C. Koner
Bidhan C. Koner
The present study was conducted from July 1, 2020 to September 25, 2020 in a dedicated coronavirus disease 2019 (COVID‐19) hospital in Delhi, India to provide evidence for the presence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus in atmospheric air and surfaces of the hospital wards. Swabs from hospital surfaces (patient's bed, ward floor, and nursing stations area) and suspended particulate matter in ambient air were collected by a portable air sampler from the medicine ward, intensive care unit, and emergency ward admitting COVID‐19 patients. By performing reverse‐transcriptase polymerase chain reaction (RT‐PCR) for E‐gene and RdRp gene, SARS‐CoV‐2 virus was detected from hospital surfaces and particulate matters from the ambient air of various wards collected at 1 and 3‐m distance from active COVID‐19 patients. The presence of the virus in the air beyond a 1‐m distance from the patients and surfaces of the hospital indicates that the SARS‐CoV‐2 virus has the potential to be transmitted by airborne and surface routes from COVID‐19 patients to health‐care workers working in COVID‐19 dedicated hospital. This warrants that precautions against airborne and surface transmission of COVID‐19 in the community should be taken when markets, industries, educational institutions, and so on, reopen for normal activities.

1 December 2016 in Journal of Theoretical Biology
Verified
Journal Article
Closed access
RJRavi Jain
Ravi Jain
Subash Chandra SonkarSubash Chandra Sonkar
Subash Chandra Sonkar
UCUma Chaudhry
Uma Chaudhry
MBManju Bala
Manju Bala
DSDaman Saluja
Daman Saluja